MedTrace Logo

Trends in the Epidemiology and Treatment of Atopic Dermatitis in the United Kingdom (UK)

NCT03823794 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 148166

Last updated 2025-06-06

Study results available
· View outcomes & findings →

Summary

Atopic dermatitis (AD), commonly called eczema, is one of the most frequently occurring skin conditions. It is estimated to affect around one fifth of children in developed countries and is also becoming increasingly common in less developed countries. Exact estimates of how common eczema is, vary considerably and there has not been an in-depth analysis of the number of people with eczema in the UK. It is also unclear which groups of people are most affected and which treatment options are being used.

Most people with eczema are managed by their general practitioner (GP) with only a few people requiring specialist care. GP records therefore provide an excellent opportunity to explore how common eczema is and which treatments are being used currently.

Conditions

Interventions

OTHER

No intervention

Observational analysis of usual care only

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY

  • Oxford Royal College of General Practitioners Research and Surveillance Centre

    collaborator UNKNOWN

  • Momentum Data

    lead INDUSTRY

Principal Investigators

  • Andrew McGovern, MD · Momentum Data Ltd

Eligibility

Min Age
0 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-02-01
Primary Completion
2020-11-04
Completion
2020-11-04

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03823794 on ClinicalTrials.gov